abstract |
There are disclosed beta -sheet mimetics and methods relating to the same for imparting or stabilizing the beta -sheet structure of a peptide, protein or molecule. In one aspect, the beta -sheet mimetics are covalently attached at the end or within the length of the peptide or protein. The beta -sheet mimetics have utility as inhibitors of one or more of proteases, kinases, CAAX, peptides binding to SH2 domains and MHC-I and/or MHC-II presentation of peptides to T cell receptors in warm-blooded animals. |